Viela Bio
Edit

Viela Bio

https://www.horizontherapeutics.com/
Last activity: 12.08.2024
Active
Categories: BioTechContentDevelopmentHealthTechInformationMedTechPagePersonalScienceTime
Community Guidelines and Terms of Use

Through this page, we look forward to sharing stories and information about Horizon. We invite you to add to the conversation by sharing your story, asking questions and commenting within the community. We will do our best to respond to any posts, comments, and questions, but it may take our team some time to respond.

We observe Facebook’s Principles and Community Standards and would ask that you observe them too. As a biotechnology company, we operate in a highly regulated industry and must adhere to certain laws and regulations. Therefore, all comments submitted to our page must be monitored and reviewed and may be subject to removal. To help ensure that your comments will be taken into consideration and posted, please adhere to the following community rules:

- We aim to provide a welcoming community for all: Posts, comments, images or any other content that is profane, defamatory, libelous, offensive, abusive, discriminatory, demeaning, disparaging, threatening, repetitive, and/or disruptive to the community, spam (including links), or impersonating others may be removed.

- We often share from the community: Occasionally we may share links to informative third-party sites that you may find useful. Horizon does not endorse and is not responsible for the content of these third-party sites.

- We strive to safeguard your personal information: For your protection, we may remove any posts/comments that contain any personal, proprietary, confidential, sensitive, or nonpublic information, such as your e-mail or phone number.

- We share tips but we are not your healthcare provider. You should always talk to your healthcare team: Any information provided here is not a substitute for medical advice from a healthcare professional. Always visit or speak to a qualified healthcare professional regarding your medical conditions.

- We respect the environment in which we work: Due to regulations, all mentions of product names, product-specific information, and specific names of healthcare professionals or facilities may be removed by a community manager.

- We invite all to share their perspectives: Comments shared within this community are not necessarily reflective of the beliefs and opinions of Horizon. We are not responsible for the accuracy of comments not posted by Horizon and do not permit comments promoting products or services.

If you believe you have had an adverse event or side effect possibly due to a Horizon Therapeutics medication please report these immediately to http://www.fda.gov/medwatch or by calling 1-800-FDA-1088. Should comments or questions include any reports of adverse events associated with our medicines, we may need to contact you to
find out more information.

In accordance with Facebook’s Community Standards, we reserve the right to block or remove any user who does not follow our community guidelines. We also reserve the right to update our community rules or remove this page, or any of its posts or comments, at any time.

This page is intended for adults in the U.S.

Terms of Use: https://www.horizontherapeutics.com/legal/legal-notice

Website: https://www.horizontherapeutics.com/
Likes
8.42K
Followers
4.34K
Followers
3.89K
Website visits
80.6K /mo.
Mentions
32
Location: United States, Maryland, Gaithersburg
Employees: 1001-5000
Phone: +1 224-383-3000
Total raised: $23M
Founded date: 2008

Investors 3

Funding Rounds 2

DateSeriesAmountInvestors
18.03.2010-$8M-
04.01.2007-$15M-

Mentions in press and media 32

DateTitleDescription
12.08.2024Ocumension (01477.HK) Demonstrates Strong Operational Resilience, Commercialization Capabilities Reach New HeightsSHANGHAI, Aug. 12, 2024 /PRNewswire/ -- On August 12, Ocumension Therapeutics (Shanghai) Co., Ltd. (01477.HK, hereinafter referred to as "Ocumension" or the "Company") released its 2024 Interim Results Report. During the...
12.08.2024Ocumension (01477.HK) Demonstrates Strong Operational Resilience, Commercialization Capabilities Reach New HeightsSHANGHAI, Aug. 12, 2024 /PRNewswire/ -- On August 12, Ocumension Therapeutics (Shanghai) Co., Ltd. (01477.HK, hereinafter referred to as "Ocumension" or the "Company") released its 2024 Interim Results Report. During the...
14.04.2024FTC chair Lina Khan on playing "anti-monopoly"Monopoly is the game where you bankrupt competitors, buying up the board and charging sky-high prices. But in Washington, Lina Khan is playing a different game: Anti-Monopoly. "The experience is not quite akin to playing a board game, ...
04.04.2024OMNICOM MEDIA GROUP RANKED #1 FOR NET NEW BUSINESS FOR SECOND CONSECUTIVE YEAROMG's Hearts & Science Tops Agency Network Ranking Group Sweeps the Network Rankings with All OMG Agencies Ranked in the Top Five NEW YORK, April 4, 2024 /PRNewswire/ -- Omnicom Media Group (OMG), the media services division of Omnicom ...
27.06.2023Rare Disease Patient Advocates Gather in San Diego for a Week of Events to Connect, Learn, and EmpowerWeek in RARE events "We are creating an unparalleled opportunity for rare disease advocates to engage with each other, build relationships, and help them understand what they can do to change what it means to live with a rare disease d...
07.06.2023Prevent Blindness Launches Multiple Efforts to Provide Education and Resources on the Effects of Vision Loss and Blindness on Mental HealthPrevent Blindness offers new resources to raise awareness and provide education for patients, care partners and healthcare service professionals, on mental wellness and vision loss. "As a patient advocacy organization, we’ve heard for ...
21.02.2023Illinois Society for the Prevention of Blindness Partners with Horizon Therapeutics to Provide Grants for Low Vision Equipment for Illinois Residents in NeedThe Illinois Society for the Prevention of Blindness, and Horizon Therapeutics are partnering to provide grants for low vision aids to Illinois patients in need. “Unfortunately, low vision equipment, which can be very expensive, is not cove...
24.01.2023Rule 17 (b) Announcement – Horizon Therapeutics plcNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION Horizon Therapeutics plc HZNP: RECOMME...
24.01.2023Rule 17 (a) Announcement – Horizon Therapeutics plcNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION Horizon Therapeutics plc HZNP: RECOMME...
12.12.2022Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plcHorizon Therapeutics plc HZNP: NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION THIS AN...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In